PL374358A1 - Koniugaty immunogenne - Google Patents
Koniugaty immunogenneInfo
- Publication number
- PL374358A1 PL374358A1 PL03374358A PL37435803A PL374358A1 PL 374358 A1 PL374358 A1 PL 374358A1 PL 03374358 A PL03374358 A PL 03374358A PL 37435803 A PL37435803 A PL 37435803A PL 374358 A1 PL374358 A1 PL 374358A1
- Authority
- PL
- Poland
- Prior art keywords
- immunogenic conjugates
- immunogenic
- conjugates
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0213878.2A GB0213878D0 (en) | 2002-06-17 | 2002-06-17 | Use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374358A1 true PL374358A1 (pl) | 2005-10-17 |
Family
ID=9938722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374358A PL374358A1 (pl) | 2002-06-17 | 2003-06-17 | Koniugaty immunogenne |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060110400A1 (pl) |
| EP (1) | EP1515989A1 (pl) |
| JP (1) | JP2006512049A (pl) |
| CN (1) | CN1675241A (pl) |
| AU (1) | AU2003277090A1 (pl) |
| CA (1) | CA2489724A1 (pl) |
| GB (1) | GB0213878D0 (pl) |
| NZ (1) | NZ537634A (pl) |
| PL (1) | PL374358A1 (pl) |
| RU (1) | RU2004139053A (pl) |
| WO (1) | WO2003106487A1 (pl) |
| ZA (1) | ZA200500199B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| FR2859725B1 (fr) * | 2003-09-16 | 2006-03-10 | Neovacs | Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine |
| ES2617062T3 (es) * | 2004-02-05 | 2017-06-15 | The Ohio State University Research Foundation | Péptidos VEGF quiméricos |
| US8921528B2 (en) | 2004-06-01 | 2014-12-30 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
| PT1844337E (pt) | 2005-01-24 | 2014-04-03 | Pepscan Systems Bv | Compostos ligantes, compostos imunogénicos e peptidomiméticos |
| US7691396B2 (en) * | 2005-06-15 | 2010-04-06 | The Ohio State University Research Foundation | Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes |
| WO2008006187A2 (en) * | 2006-07-12 | 2008-01-17 | Legeev, Yury V. | Protein complexes for prevention and treatment of diseases with angiogenesis disorders |
| EP2052253A2 (en) * | 2006-07-26 | 2009-04-29 | Pepscan Systems B.V. | Immunogenic compounds and protein mimics |
| US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| CN102936277B (zh) * | 2011-12-29 | 2014-10-01 | 北京五康新兴科技有限公司 | 人血管内皮生长因子抗原表位及其表位疫苗 |
| KR102205077B1 (ko) | 2012-08-31 | 2021-01-20 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | Ｖｅｇｆ-특이적 에피토프 및/또는 안지오포이에틴-2-특이적 에피토프를 함유하는 ｄｎａ 백신 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3374795A (en) * | 1994-08-29 | 1996-03-22 | Prizm Pharmaceuticals, Inc. | Conjugates of vascular endothelial growth factor with targeted agents |
-
2002
- 2002-06-17 GB GBGB0213878.2A patent/GB0213878D0/en not_active Ceased
-
2003
- 2003-06-17 RU RU2004139053/13A patent/RU2004139053A/ru not_active Application Discontinuation
- 2003-06-17 EP EP03740745A patent/EP1515989A1/en not_active Withdrawn
- 2003-06-17 WO PCT/GB2003/002596 patent/WO2003106487A1/en not_active Ceased
- 2003-06-17 CA CA002489724A patent/CA2489724A1/en not_active Abandoned
- 2003-06-17 AU AU2003277090A patent/AU2003277090A1/en not_active Abandoned
- 2003-06-17 NZ NZ537634A patent/NZ537634A/en unknown
- 2003-06-17 US US10/517,306 patent/US20060110400A1/en not_active Abandoned
- 2003-06-17 CN CNA038185733A patent/CN1675241A/zh active Pending
- 2003-06-17 PL PL03374358A patent/PL374358A1/pl unknown
- 2003-06-17 JP JP2004513318A patent/JP2006512049A/ja active Pending
-
2005
- 2005-01-01 ZA ZA200500199A patent/ZA200500199B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2004139053A (ru) | 2005-08-27 |
| NZ537634A (en) | 2007-03-30 |
| GB0213878D0 (en) | 2002-07-31 |
| US20060110400A1 (en) | 2006-05-25 |
| JP2006512049A (ja) | 2006-04-13 |
| ZA200500199B (en) | 2006-12-27 |
| AU2003277090A1 (en) | 2003-12-31 |
| EP1515989A1 (en) | 2005-03-23 |
| CA2489724A1 (en) | 2003-12-24 |
| WO2003106487A1 (en) | 2003-12-24 |
| CN1675241A (zh) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL376950A1 (pl) | Immunogenna kompozycja | |
| PL374534A1 (pl) | Kompozycje immunogenne | |
| AU2003253048A1 (en) | Tubulysin conjugates | |
| GB0209896D0 (en) | Conjugate | |
| GB0226722D0 (en) | Vaccine | |
| GB0225788D0 (en) | Vaccine | |
| ZA200500199B (en) | Immunogenic conjugates | |
| AU2003285320A8 (en) | Vaccine | |
| GB0119665D0 (en) | Conjugates | |
| GB0228715D0 (en) | Vaccine | |
| GB0209878D0 (en) | Vaccine | |
| PL376534A1 (pl) | Szczepionka | |
| GB0221778D0 (en) | Conjugate | |
| AU2003250828A8 (en) | Immunogenic compositions | |
| AU2003237701A8 (en) | Vaccines | |
| AU2003292197A8 (en) | Lna-cpg conjugates | |
| IL156434A0 (en) | Vaccine | |
| GB0206595D0 (en) | Vaccine | |
| GB0211007D0 (en) | Immunogenic complexes | |
| GB0226179D0 (en) | Vaccine | |
| GB0223355D0 (en) | Vaccine | |
| GB0225543D0 (en) | Immunogenic composition | |
| SI1511768T1 (sl) | Imunogenski sestavki | |
| HK1076040A (en) | Ghrelin-carrier conjugates | |
| GB0216582D0 (en) | Vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |